Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

ECP Antibody (C3): sc-517595

0.0(0)
Write a reviewAsk a question

Datasheets
  • ECP Antibody (C3) is a mouse monoclonal IgG2b λ ECP antibody provided at 100 µg/ml
  • raised against recombinant ECP of human origin
  • recommended for detection of ECP of human origin by WB, IF and IHC(P)
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for ECP Antibody (C3). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    ECP Antibody (C3) is a mouse monoclonal IgG2b antibody that detects ECP protein of human origin by western blotting (WB), immunofluorescence (IF), and immunohistochemistry. Anti-ECP antibody (C3) is available as the non-conjugated form. Eosinophil cationic protein (ECP), also known as RNS3 or RNASE3, is a 160 amino acid potent cytotoxic secretory protein that belongs to the pancreatic ribonuclease family. ECP is primarily localized in the granule matrix of eosinophils, which are crucial for the immune response, particularly in combating parasitic infections and mediating allergic reactions. The localization of ECP within eosinophil granules enables rapid release of this cytotoxic protein upon activation, allowing a swift immune response. ECP functions as a cytotoxin, neurotoxin, and helminthotoxin, exhibiting anti-parasitic, antibacterial, and ribonucleolytic activities. ECP has been implicated in the neurotoxic effects associated with the Gordon phenomenon, a syndrome characterized by ataxia, muscular rigidity, paralysis, and tremor, which can be fatal. Elevated levels of ECP are often observed in conditions of eosinophilic inflammation, such as active asthma and other allergic diseases, making ECP a valuable marker for diagnosing and monitoring these conditions.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    ECP Antibody (C3) References:

    1. Eosinophil cationic protein: is it useful in asthma? A systematic review.  |  Koh, GC., et al. 2007. Respir Med. 101: 696-705. PMID: 17034998
    2. Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes.  |  Munthe-Kaas, MC., et al. 2007. Allergy. 62: 429-36. PMID: 17362255
    3. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.  |  Torrent, M., et al. 2008. Biochemistry. 47: 3544-55. PMID: 18293932
    4. Characterization of molecular interactions between eosinophil cationic protein and heparin.  |  Fan, TC., et al. 2008. J Biol Chem. 283: 25468-25474. PMID: 18593710
    5. [Evaluation of eosinophil cationic protein levels with clinical symptoms and laboratory findings of patients with cystic echinococcosis].  |  Cicioğlu Aridoğan, B., et al. 2009. Mikrobiyol Bul. 43: 285-92. PMID: 19621614
    6. Eosinophils and cellular injury: the Gordon phenomenon as a model.  |  Fredens, K., et al. 1985. N Engl Reg Allergy Proc. 6: 346-51. PMID: 3916590
    7. The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X.  |  Fredens, K., et al. 1982. J Allergy Clin Immunol. 70: 361-6. PMID: 7130551
    8. Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity.  |  Rosenberg, HF. 1995. J Biol Chem. 270: 7876-81. PMID: 7713881
    9. Toxicity of an antitumor ribonuclease to Purkinje neurons.  |  Newton, DL., et al. 1994. J Neurosci. 14: 538-44. PMID: 8301353

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    ECP Antibody (C3)

    sc-517595
    100 µg/ml
    $322.00